| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $284.9M | +24.8% |
| Cost of Revenue | $128.5M | +43.9% |
| Gross Profit | $156.4M | +12.6% |
| R&D Expense | $68.5M | -7.3% |
| SG&A Expense | $51.5M | -39.4% |
| Operating Income | -$19.1M | +74.5% |
| Pre-tax Income | $61K | +100.1% |
| Income Tax | $958K | +318.3% |
| Net Income | -$897K | +98.5% |
| EPS (Basic) | -$0.01 | +97.2% |
| EPS (Diluted) | -$0.01 | +97.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $286.8M | +3.1% |
| Accounts Receivable | $61.6M | -12.3% |
| Current Assets | $448.3M | -0.5% |
| Total Assets | $754.8M | +1.6% |
| Current Liabilities | $59.6M | -22.8% |
| Total Liabilities | $71.6M | -21.7% |
| Stockholders' Equity | $683.2M | +4.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $39.7M | +704.3% |
| Capital Expenditures | $883K | +849.5% |
| Investing Cash Flow | -$16.9M | +13.4% |
| Financing Cash Flow | -$14.3M | +68.8% |
| Free Cash Flow | $38.8M | +682.6% |